Torthaí cuardaigh - Sibyl Anderson
- 1 - 8 toradh as 8 á dtaispeáint
-
1
Combined modality chemoradiation in elderly oesophageal cancer patients de réir Sibyl Anderson, Bruce D. Minsky, Manjit S. Bains, Amanda Hummer, David P. Kelsen, David H. Ilson
Foilsithe / Cruthaithe 2007Artigo -
2
Phase II Study of Doxorubicin and Bevacizumab for Patients With Metastatic Soft-Tissue Sarcomas de réir David R. D’Adamo, Sibyl Anderson, Karen Albritton, Jennifer Yamada, Elyn Riedel, Kelly Scheu, Gary K. Schwartz, Helen Chen, Robert G. Maki
Foilsithe / Cruthaithe 2005Artigo -
3
Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial de réir Tim Eisen, Stéphane Oudard, Cezary Szczylik, Gwénaëlle Gravis, Hans Heinzer, Richard G. Middleton, Frank Cihon, Sibyl Anderson, Sonalee Shah, Ronald M. Bukowski, Bernard Escudier
Foilsithe / Cruthaithe 2008Artigo -
4
Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma de réir Mario M. Leitão, Robert A. Soslow, Daisuke Nonaka, Adam B. Olshen, Carol Aghajanian, Paul Sabbatini, Jakob Dupont, Martee L. Hensley, Yukio Sonoda, Richard R. Barakat, Sibyl Anderson
Foilsithe / Cruthaithe 2004Artigo -
5
Early Detection and Prognosis of Ovarian Cancer Using Serum YKL-40 de réir Jakob Dupont, Meena K. Tanwar, Howard T. Thaler, Martin Fleisher, Noah D. Kauff, Martee L. Hensley, Paul Sabbatini, Sibyl Anderson, Carol Aghajanian, Eric C. Holland, David R. Spriggs
Foilsithe / Cruthaithe 2004Artigo -
6
VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+/HER2- advanced breast cancer de réir Erika Hamilton, X. Cynthia, Michelino De Laurentiis, Hiroji Iwata, Sara A. Hurvitz, Seth A. Wander, Michael A. Danso, Dongrui R. Lu, Julia Perkins Smith, Yuan Liu, Lana Tran, Sibyl Anderson, Mario Campone
Foilsithe / Cruthaithe 2024Artigo -
7
Development and Evaluation of an Automated Multimodal Mobile Detection of Oral Cancer (mDOC) Imaging System to Aid in Risk-based Management of Oral Mucosal Lesions de réir Ruchika Mitbander, David Brenes, Jackson B. Coole, Alex Kortum, Imran S. Vohra, Jennifer Carns, Richard A. Schwarz, Ida Varghese, Safia Durab, Sibyl Anderson, Nancy Bass, Anthony B. Clayton, Hawraa Badaoui, Loganayaki Anandasivam, Rachel Giese, Ann M. Gillenwater, Nadarajah Vigneswaran, Rebecca Richards‐Kortum
Foilsithe / Cruthaithe 2025Artigo -
8
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial de réir Bernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard, Michael Staehler, Sylvie Négrier, Christine Chevreau, Apurva A. Desai, Frédéric Rolland, Tomasz Demkow, Thomas E. Hutson, Martin Gore, Sibyl Anderson, Gloria Hofilena, Minghua Shan, Carol Peña, Chetan Lathia, Ronald M. Bukowski
Foilsithe / Cruthaithe 2009Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Internal medicine
Medicine
Cancer
Oncology
Biology
Breast cancer
Chemotherapy
Clinical trial
Confidence interval
Hazard ratio
Paleontology
Pathology
Stage (stratigraphy)
Alternative medicine
Estrogen receptor
Gastroenterology
Hepatocellular carcinoma
Placebo
Renal cell carcinoma
Sorafenib
Adenocarcinoma
Androgen
Androgen receptor
Bevacizumab
Biochemistry
Chemistry
Clinical endpoint
Cohort
Comorbidity
Doxorubicin